Rockville, MD, United States of America

Chun-Hsien Huang


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Chun-Hsien Huang

Introduction

Chun-Hsien Huang is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of immunology, particularly through his innovative work on isothiazolones. His expertise and dedication have led to the development of valuable patents that enhance our understanding and application of immunoassays.

Latest Patents

Chun-Hsien Huang holds a patent for an "Immunoassay for isothiazolones." This patent focuses on the use of monoclonal antibodies that react specifically with isothiazolones, including 5-chloro-2-methyl-3-isothiazolone. The patent also details hybridomas that produce such antibodies, particularly ATCC HB 11435. Additionally, it outlines methods for preparing immunogenic conjugates of isothiazolones with macromolecule carriers, as well as methods for producing monoclonal antibodies that are reactive with isothiazolones. The patent includes compositions that comprise monoclonal or polyclonal antibodies reactive with isothiazolones.

Career Highlights

Chun-Hsien Huang is associated with Rohm and Haas Company, where he has applied his innovative skills to advance research and development in his field. His work has not only contributed to the company’s portfolio but has also had a broader impact on the scientific community.

Collaborations

Chun-Hsien Huang has collaborated with notable colleagues such as Gary L Willingham and Richard F Schuman. These collaborations have fostered an environment of innovation and have led to significant advancements in their respective fields.

Conclusion

Chun-Hsien Huang's contributions to the field of immunology through his patent on isothiazolones exemplify the importance of innovation in scientific research. His work continues to influence the development of immunoassays and related technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…